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E-mail address: ysbae@knu.ac.kr (Y.-S. Bae).We have shown that protein kinase CKII (CKII) inhibition induces senescence through the p53-
dependent pathway in HCT116 cells. Here we examined the molecular mechanism through which
CKII inhibition activates p53 in HCT116 cells. CKII inhibition by treatment with CKII inhibitor or
CKIIa small-interfering RNA (siRNA) increased intracellular hydrogen peroxide and superoxide
anion levels. These effects were signiﬁcantly blocked by pretreatment of cells with the antioxidant
N-acetylcysteine. Additionally, NADPH oxidase (NOX) inhibitor apocynin and p22phox siRNA signiﬁ-
cantly reduced p53 expression and suppressed the appearance of senescence markers. CKII inhibi-
tion did not affect mitochondrial superoxide generation. These data demonstrate that CKII
inhibition induces superoxide anion generation via NOX activation, and subsequent superoxide-
dependent activation of p53 acts as a mediator of senescence in HCT116 cells after down-regulation
of CKII.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Normal primary cells withdraw from the cell division cycle after
a variable number of cell divisions and enter an irreversible growth
arrest state that is designated replicative senescence or, more gen-
erally, cellular senescence [1]. Cellular senescence can also be in-
duced by oxidative stress, DNA damage, histone deacetylase
inhibitor, and expression of the active form of oncoproteins such
as Ras and Raf [2–6]. In the state of senescence, cells become en-
larged, acquire a ﬂattened morphology, and express several senes-
cence-associated markers, including senescent-associated b-
galactosidase (SA-b-gal), tumour suppressor protein p53, and cy-
clin-dependent kinase inhibitor p21Waf-1 [5,7–10]. p53 is a potent
transcription factor that plays a key role in cell cycle regulation.chemical Societies. Published by E
wn as casein kinase II); DCF,
dichloro-1-b-D-ribofuranosyl-
m; NAC, N-acetyl-L-cysteine;
line; ROS, reactive oxygen
dase; SDS, sodium dodecylIt is activated in response to a variety of cellular stress signals
including DNA damage, and triggers cell cycle arrest or apoptosis,
depending on the circumstances, to prevent cells from undergoing
transformation.
Protein kinase CKII (formerly known as casein kinase II) (CKII),
which is a ubiquitous and highly conserved protein serine/threo-
nine kinase, plays a signiﬁcant role in the control of cell prolifera-
tion and transformation [11–13]. The holoenzyme of CKII is a
heterotetramer, composed of two catalytic (a and/or a0) and two
regulatory (b) subunits. We have previously shown evidence that
CKII activity is down-regulated at the transcription level in both
senescent human lung ﬁbroblast IMR-90 cells and aged rat tissues.
CKII inhibition by CKII inhibitors or CKIIa siRNA induces premature
senescence of the IMR-90 cells [14]. In addition, silencing of CKIIa
and CKIIa0 genes during cellular senescence is mediated by DNA
methylation [15]. Studies designed to examine the mechanism by
which CKII inhibition contributes to development of senescence
indicated that the p53-p21Cip1/WAF1 pathway is involved in the
development of senescence induced by CKII inhibition [16]. In
the present study, we show that reactive oxygen species (ROS)
generating capability is the upstream cause of p53 stabilization
in cells made senescent by CKII inhibition. We provide evidencelsevier B.V. All rights reserved.
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via NADPH oxidase (NOX) activation in HCT116 cells.2. Materials and methods
2.1. Cell culture and SA-b-gal activity assay
The HCT116 human colon cancer cells were cultured in Dul-
becco’s modiﬁed Eagle’s medium (DMEM) containing 10% (v/v) fe-
tal bovine serum under a humidiﬁed atmosphere of 5% (v/v) CO2 at
37 C. SA-b-gal activity was measured as described previously [8]
with minor modiﬁcations. Cells in sub-conﬂuent cultures were
washed with ice-cold phosphate-buffered saline (PBS), ﬁxed in 3%
(v/v) formaldehyde in PBS for 10 min at room temperature, and
then incubated with a stain solution containing 1 mg/ml 5-bro-
mo-4-chloro-3-indolyl b-D-galactoside, 40 mM citric acid–sodium
phosphate (pH 6.0), 5 mM potassium ferricyanide, 5 mM potassium
ferrocyanide, 150 mM NaCl, and 2 mM MgCl2 for 24 h at 37 C. The
number of blue-stained cells was counted in at least 10 ﬁelds at 20
magniﬁcation and expressed as percentage of positive cells.
2.2. RNA interference
The small-interfering RNA (siRNA) for CKIIa was 50-UCA-
AGAUGACUACCAGCUGdTdT. The siRNA for the negative control
was 50-GCUCAGAUCAAUACGGAGAdTdT. The siRNA for p22phox
was obtained from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA). siRNAs were transfected into cells by using Lipofectamine
(Invitrogen, Carlsbad, CA) as described by the manufacturer. At
48 h after the transfection, the cells were harvested or stained for
SA-b-gal activity.
2.3. Measurement of intracellular ROS
The oxidation-sensitive ﬂuorescent probes CM-H2DCFDA, dihy-
droethidium (DHE), and MitoSOX Red were used to monitor pro-
duction of hydrogen peroxides, cytosolic superoxide anions, and
mitochondrial superoxides, respectively. Probes were purchased
from Invitrogen. HCT116 cells were treated with CKII inhibitors
for 4 days and then were incubated with 5 lM CM-H2DCFDA,
DHE, or MitoSOX Red for 20 min at 37 C in the dark. Some cells
were pre-incubated with 10 mM N-acetyl-L-cysteine (NAC) or
20 lM apocynin for 2 h before treatment with CKII inhibitors.
The cells were rinsed twice with PBS, and digital images were ob-
tained with a Leica DM IRB inverted microscope (Leica Microsys-
tems, Germany) equipped with a coolsnap HQ camera (Roper
Scientiﬁc, NJ) operated by Metamorph Image Software (Universal
Imaging Corporation, PA). For ﬂow cytometry analysis, cells in cul-
ture dishes were detached by trypsinization and washed with PBS.
Fluorescence intensity was determined with a Coulter Elite ESP
Cell Sorter (Beckman Coulter Inc., Brea, CA). The forward and side
scatter gates were set to exclude any dead cells from the analysis;
at least 10 000 events within this gate were acquired per sample.
2.4. Preparation of cell extracts
HCT116 cells in 60 mm-dishes were washed with ice-cold PBS,
collected by scraping with a rubber policeman, and lysed in 100 ll
of ice-cold RIPA buffer [50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 1%
NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate
(SDS), 0.5 mM PMSF, 1 lg/ml aprotinin, 1 lg/ml leupeptin, 1 lg/
ml pepstatin]. Protein concentration in the supernatants was
determined using Bradford protein dye reagent (Bio-Rad, CA),
and the volumes of the supernatants were adjusted for equal pro-
tein concentration.2.5. Immuno-blotting
Proteins were separated on 12% polyacrylamide gels in the
presence of SDS, and then transferred by electrophoresis to nitro-
cellulose membranes. The membranes were blocked with 5% (w/
v) non-fat, dry skim milk in TBST [20 mM Tris–HCl (pH 7.4),
150 mM NaCl, 0.05% Tween 20] for 2 h and then incubated with
speciﬁc antibodies in 1% (w/v) non-fat, dry skim milk for 1 h. The
membranes were washed three times in TBST, and then treated
with ECL system (Amersham Pharmacia Biotech, Korea). Some
membranes were stripped in stripping buffer [2% SDS, 100 mM b-
mercaptoethanol, and 50 mM Tris–HCl (pH 7.0)] at 50 C for 1 h
with gentle shaking and reprobed with anti-b-actin antibody as a
control for protein loading. Anti-CKIIa antibodies were from Cal-
biochem Co. (San Diego, CA). Antibodies to p53, p22phox, and b-ac-
tin were from Santa Cruz Biotechnology Inc.
2.6. Statistical analysis
The statistical signiﬁcance of SA-b-gal staining data was ana-
lyzed by one-way ANOVA with the SPSS package program. The re-
sults were considered signiﬁcant if the value of P was less than
0.05. Duncan’s multiple-range test was performed if the differ-
ences between the groups were identiﬁed as a = 0.05.3. Results and discussion
3.1. CKII inhibition increases production of hydrogen peroxide and
superoxide anion in HCT116 cells
We have previously demonstrated that CKII inhibition induces
senescence through the p53-dependent pathway in HCT116 cells.
To examine whether the ROS generating capability could be one
of the upstream causes of p53 stabilization in cells made senescent
by CKII inhibition, HCT116 cells were incubated with CM-
H2DCFDA. CM-H2DCFDA is hydrolysed to DCFH in the cell, and
DCFH is oxidized by hydrogen peroxide via intracellular peroxi-
dases to yield the ﬂuorescent dichloroﬂuorescein (DCF) [17].
Fig. 1A shows representative images of DCF ﬂuorescence in un-
treated cells and in cells treated with CKII inhibitors apigenin
and 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole (DRB). In con-
trol cells, the hydrogen peroxide-related signal was not observed.
However, CKII inhibitors signiﬁcantly increased the hydrogen per-
oxide production as indicated by both the green ﬂuorescence on
confocal images and the rightward shift in ﬂuorescence on ﬂow
cytometry. Incubation with NAC, which is a commonly used scav-
enger of ROS, apparently prevented the ﬂuorescent signal in the
CKII inhibitor-treated cells. To conﬁrm the production of hydrogen
peroxide in cells with down-regulated CKII, we knocked down
CKIIa in HCT116 cells by gene silencing with siRNA duplexes
(Fig. 1C). As shown in Fig. 1B, transfection of CKIIa siRNA also
markedly increased hydrogen peroxide production; NAC sup-
pressed this production.
Hydrogen peroxide is produced by a reaction catalysed by
superoxide dismutase (SOD) from superoxide anion (O2), which
is a key radical in ROS generation. To detect superoxide anion,
we incubated HCT116 cells with DHE, which is oxidized to the ﬂuo-
rescent ethidium (ETH). DHE is relatively speciﬁc for superoxide
anion and reacts only minimally with hydrogen peroxide [18]. As
shown in Fig. 2A and B, CKII inhibitors and CKIIa siRNA signiﬁ-
cantly increased superoxide anion level relative to that in un-
treated control cells, as indicated by both the red ﬂuorescence on
confocal images and the rightward shift in ﬂuorescence on ﬂow
cytometry. The presence of NAC suppressed CKII inhibitor-medi-
ated superoxide anion generation. Taken together, these results
Fig. 1. CKII inhibition increases production of hydrogen peroxide in HCT116 cells. (A) HCT116 cells were treated with a CKII inhibitor, either apigenin (20 lM) or DRB
(20 lM), in the presence or absence of NAC for four days (upper panel). Some cells were transfected with p22phox siRNA in the presence or absence of a CKII inhibitor for four
days (bottom panel). (B) HCT116 cells were transfected with CKIIa siRNA in the presence or absence of NAC for four days. The cells were then incubated with CM-H2DCFDA as
described in Section 2. Representative confocal images illustrate green ﬂuorescence intensity of DCF produced by ROS (original magniﬁcation 200). Fluorescence intensity
was determined by ﬂow cytometry analysis. (C) HCT116 cells were transfected with indicated siRNAs in the presence or absence of CKII inhibitors and antioxidants for four
days. The cells were lysed, electrophoresed on a 12% (w/v) SDS–polyacrylamide gel, and visualized by immunoblot with anti-p22phox (left panel) and anti-CKIIa (right panel)
antibodies.
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sources of ROS produced by CKII inhibition.
3.2. NOX, but not mitochondria, is involved in CKII inhibition-mediated
superoxide anion production
The NOX family of enzymes, NOX1—NOX5 and Duox 1 and 2,
produce superoxide anion using NADPH as the electron donor
[19]. We investigated whether NOX is involved in an enhanced
superoxide anion production in cells with down-regulated CKII.
To examine the involvement of NOX in the cellular responses sub-
sequent to CKII inhibition, cells were incubated with the NOX
inhibitor apocynin (0.5 mM). The presence of apocynin signiﬁ-
cantly suppressed CKII inhibitor- or CKIIa knockdown-inducedsuperoxide anion generation (Fig. 2A and B). All NOX isoforms ap-
peared to have a mutual stabilizing relationship with the p22phox
subunit [20,21]. Mutations of the proline-rich region of p22phox re-
duced ROS generation [22], suggesting that p22phox is a common
integral component of the electron-transporting machinery for
NOX family enzymes. Thus, we knocked down p22phox by using
siRNA in CKII-inhibited cells to conﬁrm the role of NOX in the CKII
inhibition-derived superoxide generation (Fig. 1C). Transfection of
p22phox siRNA markedly decreased the CKII inhibition-mediated
generation of hydrogen peroxide and superoxide anion (Figs. 1A
and 2A).
Superoxide anion generation may originate from mitochondria.
To investigate whether CKII inhibition affects the mitochondrial
superoxide generation, we stained HCT116 cells with MitoSOX
Fig. 2. CKII inhibition increases superoxide anion generation in HCT116 cells. (A) HCT116 cells were treated with apigenin or DRB in the presence or absence of NAC or
apocynin for four days (upper panel). Some cells were transfected with p22phox siRNA in the presence or absence of CKII inhibitors for four days (bottom panel). (B) HCT116
cells were transfected with CKIIa siRNA in the presence or absence of NAC or apocynin for four days. The cells were then incubated with DHE as described in Section 2.
Representative confocal images reveal the red ﬂuorescence of ETH produced by superoxide anion (original magniﬁcation 200). Fluorescence intensity was determined by
ﬂow cytometry analysis.
Fig. 3. Mitochondria are not involved in CKII inhibition-mediated superoxide anion production. (A) HCT116 cells were treated with apigenin or DRB in the presence or
absence of apocynin for four days (upper panel). Some cells were transfected with p22phox siRNA in the presence or absence of CKII inhibitors for four days (bottom panel). (B)
HCT116 cells were transfected with CKIIa siRNA in the presence or absence of apocynin for four days. The cells were then incubated with MitoSOX Red as described in
Section 2. Representative confocal images illustrate the red ﬂuorescence of MitoSOX Red produced by ROS (original magniﬁcation 200). Fluorescence intensity was
determined by ﬂow cytometry analysis. As positive control, treatment with menadione (100 lM) produced MitoSOX ﬂuorescence (data not shown).
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live cells [23]. As shown in Fig. 3, neither treatment with CKII
inhibitors nor transfection with CKIIa siRNA induced MitoSOX
ﬂuorescence, suggesting a rather limited role of mitochondria in
the augmented superoxide anion generation by CKII down-regula-
tion. In contrast, treatment with menadione as positive control
strongly induced MitoSOX ﬂuorescence (data not shown).
3.3. Inhibition of NOX antagonizes CKII inhibition-mediated cellular
senescence
We examined whether NAC and apocynin antagonize cellular
senescence induced by CKII inhibition. To detect senescence,
HCT116 cells were treated with CKII inhibitors or CKIIa siRNA
and then stained for SA-b-gal activity. As shown in Fig. 4A and B,
there was a signiﬁcant increase in SA-b-gal activity in response
to CKII inhibitors, apigenin and DRB, and CKIIa siRNA. However,
co-treatment of the cells with NAC or apocynin resulted in a de-
crease in SA-b-gal activity, demonstrating that superoxide anion
generated by NOX is involved in the induction of senescence by
CKII inhibition. We previously demonstrated that CKII inhibition
induced p53 stabilization which then caused senescence in
HCT116 cells [16]. Thus, we wanted to determine whether treat-Fig. 4. Inhibition of NOX antagonizes CKII inhibition-mediated cellular senescence. (A) H
CKIIa siRNA (right panel) in the presence or absence of NAC or apocynin (AC). Cells were
Section 2. The percentage of positively stained cells was measured. Values are mean ± S
P < 0.05. (B) HCT116 cells were treated with CKII inhibitors or CKIIa siRNA in the presenc
chloro-3-indolyl b-D-galactoside, and representative images were obtained at 20magni
presence or absence of NAC or apocynin (C). Cells were transfected with indicated siRNA
(D). Cells were lysed, and subjected to electrophoresis on a 12% (w/v) SDS–polyacrylamidment with NAC or apocynin would decrease the p53 protein level
in cells with down-regulated CKII. Immunoblot data showed that
the expression of p53 was up-regulated in cells treated with CKII
inhibitors or CKIIa siRNA compared with that in control cells. How-
ever, co-treatment with NAC or apocynin caused cells to exhibit an
apparently lower expression of p53 protein (Fig. 4C and D).
Recently we demonstrated that the activated p53–p21Cip1/WAF1
pathway acts as a major mediator of CKII inhibition-induced cellu-
lar senescence. The present study shows a possible mechanism by
which CKII inhibition might activate p53. First, DCF and ETH sig-
nals increased during CKII down-regulation, indicating that hydro-
gen peroxide and superoxide anion were being produced in the
cells. In addition, apocynin and p22phox siRNA almost completely
abolished the CKII inhibition-induced increase in DCF and ETH sig-
nals and antagonized the p53 stabilization and senescence induced
by CKII inhibition. These ﬁndings indicate that NOX-dependent
superoxide anion production is one of the upstream causes of the
CKII down-regulation-mediated senescence signaling cascade.
How does CKII down-regulation enhance superoxide anion gener-
ation? It has been previously shown that p47phox, a cytosolic sub-
unit of NOX family enzymes, can be phosphorylated by CKII and
that DRB enhances NOX activity of HL-60 cells, suggesting that CKII
plays a role in the regulation of the NOX deactivation processesCT116 cells were treated with apigenin (Api) or DRB (left panel) or transfected with
ﬁxed and stained with 5-bromo-4-chloro-3-indolyl b-D-galactoside as described in
.E. a, b, c: bars with different letters have values that are signiﬁcantly different at
e or absence of NAC or apocynin (AC). Cells were ﬁxed and stained with 5-bromo-4-
ﬁcation. (C and D) HCT116 cells were treated with CKII inhibitors for four days in the
for four days in the presence or absence of the indicated inhibitors and antioxidants
e gel, and visualized by immunoblotting with anti-p53 and anti-b-actin antibodies.
3142 S.M. Jeon et al. / FEBS Letters 584 (2010) 3137–3142[24]. Therefore, the most likely explanation is that CKII negatively
regulates NOX activity by phosphorylating the NOX subunit, and
CKII inhibition enhances NOX activity required for superoxide an-
ion generation in cells.
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